Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First patient enrolled in Phase II study evaluating JZP-110 for excessive sleepiness in Parkinson's

cphi-onlineFebruary 14, 2017

Tag: Jazz Pharmaceuticals , patient

PharmaSources Customer Service